Last reviewed · How we verify

CELLULOSE SODIUM PHOSPHATE

FDA-approved approved ✓ Verified May 2026 Quality 5/100

CELLULOSE SODIUM PHOSPHATE is a drug. It is currently FDA-approved (first approved 1982).

Cellulose sodium phosphate is not directly mentioned in the provided facts, but it is likely a component of the oral placebo tablet used in clinical trials. The trials studied various conditions, including endometrial endocrine regulation, cognitive dysfunction, and smoking addiction, but the specific role of cellulose sodium phosphate in these studies is not specified.

At a glance

Generic nameCELLULOSE SODIUM PHOSPHATE
PhaseFDA-approved
First approval1982

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about CELLULOSE SODIUM PHOSPHATE

What is CELLULOSE SODIUM PHOSPHATE?

CELLULOSE SODIUM PHOSPHATE is a pharmaceutical drug.

When was CELLULOSE SODIUM PHOSPHATE approved?

CELLULOSE SODIUM PHOSPHATE was first approved on 1982.

What development phase is CELLULOSE SODIUM PHOSPHATE in?

CELLULOSE SODIUM PHOSPHATE is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing